Investigating the expression of HER-2 and the extent of TIL infiltration, as well as their relationships with clinical pathological characteristics of BC, is of significant theoretical and practical importance for further elucidating the mechanisms underlying BC development and optimizing clinical diagnosis and treatment strategies. Here, ERBB2 is linked to breast cancer.